Τελευταία ενημέρωση :
19/11/2024
Αντιεπιληπτικό   Phenobarbital sodium  
Ενέσιμο
Σταθερότητα διαλυμάτων Σταθερότητα σε μίγματα Παράγοντας που επηρεάζει τη σταθερότητα Συμβατότητες Τρόπος χορήγησης Βιβλιογραφία pdf
   χημική δομή  

Εμπορική ονομασία   Εμπορική ονομασία     

Οι εμπορικές ονομασίες είναι ενδεικτικές και η σύνθεση των εκδόχων μπορεί να διαφέρει ανάλογα με τη χώρα και τα εργαστήρια

Carbital Βραζιλία
Fenemal Σουηδία
Fenobarb Ινδία
Fenobarbital Αργεντινή, Εκουαδόρ, Κολομβία
Gardenal Βενεζουέλα, Βραζιλία, Γαλλία, Ινδία, Μαρόκο, Μεγάλη Βρετανία, Τυνησία
Luminal Γερμανία, Ιράν, Ισπανία
Luminale Ιταλία
Luminalum Πολωνία
Phenobarbital sodium Καναδάς, Μεγάλη Βρετανία
Sominaletta Αίγυπτος
Βιβλιογραφία   Ενέσιμο   Βιβλιογραφία : Phenobarbital sodium  
τύπος δημοσίευση
58 εφημερίδα Parker WA.
Physical compatibility of ranitidine HCl with preoperative injectable medications.
Can J Hosp Pharm 1985 ; 38: 160-161.
201 εφημερίδα Thompson DF, Allen LV, Stiles ML.
Visual compatibility of enalaprilate with selected intravenous medications during simulated Y-site injection.
Am J Hosp Pharm 1990 ; 47: 2530-2531.
226 εφημερίδα Walker SE, DeAngelis C, Iazzetta J.
Stability and compatibility of combinations of hydromorphone and a second drug.
Can J Hosp Pharm 1991 ; 44: 289-295.
266 εφημερίδα Patel PR.
Compatibility of meropenem with commonly used injectable drugs.
Am J Health-Syst Pharm 1996 ; 53: 2853-2855.
300 εφημερίδα Trissel LA, Gilbert DL, Martinez JF.
Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
301 εφημερίδα Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM.
Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1295-1300.
349 εφημερίδα Nahata MC, Hipple TF, Strausbaugh SD.
Stability of phenobarbital sodium diluted in 0.9% sodium chloride injection.
Am J Hosp Pharm 1986 ; 43: 384-385.
642 εφημερίδα Baumgartner TG, Knudsen AK, Dunn AJ, Kilroy RA.
Norepinephrine stability in saline solutions.
Hosp Pharm 1988 ; 23: 44,49, 59.
660 εφημερίδα Michaels MR, Stauffer GL, Haas DP.
Propofol compatibility with other intravenous drug products - Two new methods of evaluating IV emulsion compatibility.
Ann Pharmacotherapy 1996 ; 30: 228-232.
921 εφημερίδα Trissel LA, Gilbert DL, Martinez JF.
Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration.
Hosp Pharm 1998 ; 33: 284-292.
1057 εφημερίδα Cutie MR.
Compatibility of verapamil hydrochloride injection with commonly used additives.
Am J Hosp Pharm 1983 ; 40: 1205-1207.
1072 εφημερίδα Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA.
Compatibility of levofloxacin with 34 medications during simulated Y-site administration.
Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
1412 εφημερίδα Brett A, Riggs RM, Webster AA, Benner KW.
Y-site stability of fosphenytoin and sodium phenobarbital.
Int J Pharm Compound 1999 ; 3: 64-66.
1415 εφημερίδα Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M.
Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
JPEN 1999 ; 23: 67-74.
1625 εφημερίδα Trissel LA, Saenz C, Williams YW, Ingram D.
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2001 ; 5: 314-321.
1802 εφημερίδα Bell MS, Nolt DH.
Visual compatibility of doxapram hydrochloride with drugs commonly administered via a Y-site in the intensive care nursery.
Am J Health-Syst Pharm 2003 ; 60: 193-194.
1925 εφημερίδα Trissel LA , Williams KY, Gilbert DL.
Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
J Am Pharm Assoc 2000 ; 40: 515-519.
1974 εφημερίδα Chandler SW, Trissel LA, Weinstein SM
Combined administration of opoids with selected drugs to manage pain and other cancer symptoms initial safety screening for compatibility.
J Pain Symptom Manage 1996 ; 12, 3: 168-171.
2090 εφημερίδα Pere H, Chasse V, Forest JM, Hildgen P.
Compatibility of injectable pantoprazole in Y-site administration.
Pharmactuel 2004 ; 37: 193-196.
2262 εφημερίδα Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
3379 εφημερίδα Fox L.M, Wilder A.G, Foushee J.A.
Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration.
Am J Health-Syst Pharm 2013 ;70:520-524.
3408 εφημερίδα Tollec S, Touzin K, Pelletier E, Forest J.M.
Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels.
Pharmactuel 2013 ; 46, 1 : 16-21.
3501 Εργαστήριο Ketamine hydrochloride (Ketalar®) - Summary of Product Characteristics
Pfizer 2011
3525 Εργαστήριο Pethidine hydrochloride - Summary of product Characteristics
AMCO Amdipharm Mercury 2012
3526 Εργαστήριο Clindamycin (Dalacin®) - Summary of Product Characteristics
Pharmacia 2010
3531 Εργαστήριο Morphine sulphate 10 mg/mL injection BP – Summary of Product Characteristics
Wockhardt 2014
3596 Εργαστήριο Chlorpromazine (Largactil®) - Summary of Product Characteristics
Sanofi 2014
3631 Εργαστήριο Suxamethonium (Suxamethonium Aguettant®) - Résumé des caractéristiques du produit
Aguettant 2016
3674 Εργαστήριο Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3676 Εργαστήριο Atracurium bésilate (Atracurium Hospira®) - Résumé des caractéristiques du produit
Hospira 2014
4009 Εργαστήριο
Droperidol - Résumé des Caractéristiques du Produit
Panpharma 2017
4419 εφημερίδα Holt R.J, Siegert S.W.K, Krishna A.
Physical Compatibility of Ibuprofen Lysine Injection with Selected Drugs During Simulated Y-site Injection.
J Pediatr Pharmacol Ther 2008 ; 13, 3: 155-161.
4435 εφημερίδα Hanifah S, Nugroho B.H, Chabib L.
Compatibility of acetaminophen with central nervous system medications during simulated Y-site injection.
Anaesthesiol Intensive Ther 2020 ; 52, 1: 23-27.
4543 εφημερίδα Senarathna G, Strunk T, Petrovski M, Batty K.
Physical compatibility of pentoxifylline and intravenous medications.
Archives of Disease in Childhood 2018 ;104:292–295.
4700 Εργαστήριο Esketamine 25 mg/mL solution for injection/infusion. - Summary of Product Characteristics
AS Kalceks 2022
4742 εφημερίδα Macoviciuc M, Nguyen C, Forest J-M, Leclair G.
Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y.
Pharmactuel 2022 ; 55, 4: 247-255.
4837 εφημερίδα De Silva, D.T.N Petrovski M, Strunk T, Mukadam N, Page‑Sharp N, Moore B.R, Batty K.T.
Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings.
Eur J Clin Pharmacol 2024 ; 80:1079–1087.

  Mentions Légales